Patterns of Chemotherapy Use in a U.S.‐Based Cohort of Patients with Metastatic Pancreatic Cancer

par Abrams, Thomas A., Meyer, Gary, Meyerhardt, Jeffrey A., Wolpin, Brian M., Schrag, Deborah, Fuchs, Charles S.
Publié dans Oncologist (2017)

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors

par Kulke, Matthew H., Chan, Jennifer A., Meyerhardt, Jeffrey A., Zhu, Andrew X., Abrams, Thomas A., Blaszkowsky, Lawrence S., Regan, Eileen, Sidor, Carolyn, Fuchs, Charles S.
Publié 2010

Phase I Study of Pasireotide (SOM 230) and Everolimus (RAD001) in Advanced Neuroendocrine Tumors

par Chan, Jennifer A., Ryan, David P., Zhu, Andrew X., Abrams, Thomas A, Wolpin, Brian M, Malinowski, Paige, Regan, Eileen M, Fuchs, Charles S., Kulke, Matthew H.
Publié dans Endocr Relat Cancer (2012)

Identification of Potentially Avoidable Hospitalizations in Patients With GI Cancer

par Brooks, Gabriel A., Abrams, Thomas A., Meyerhardt, Jeffrey A., Enzinger, Peter C., Sommer, Karen, Dalby, Carole K., Uno, Hajime, Jacobson, Joseph O., Fuchs, Charles S., Schrag, Deborah
Publié 2014

A Phase 2 Study of Oral MKC-1 in Patients with Unresectable or Metastatic Pancreatic Cancer

par Faris, Jason E., Arnott, Jamie, Zheng, Hui, Ryan, David P., Abrams, Thomas A., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Enzinger, Peter C., Hezel, Aram F., Ng, Kimmie, Wolpin, Brian M., Kwak, Eunice L.
Publié 2011

Panitumumab in Patients with KRAS Wild-Type Colorectal Cancer after Progression on Cetuximab

par Wadlow, Raymond C., Hezel, Aram F., Abrams, Thomas A., Blaszkowsky, Lawrence S., Fuchs, Charles S., Kulke, Matthew H., Kwak, Eunice L., Meyerhardt, Jeffrey A., Ryan, David P., Szymonifka, Jackie, Wolpin, Brian M., Zhu, Andrew X., Clark, Jeffrey W.
Publié 2012

A Phase II and Biomarker Study of Cabozantinib in Patients with Advanced Cholangiocarcinoma

par Goyal, Lipika, Zheng, Hui, Yurgelun, Matthew B., Abrams, Thomas A., Allen, Jill N., Cleary, James M., Knowles, Michelle, Regan, Eileen, Reardon, Amanda, Khachatryan, Anna, Jain, Rakesh K., Nardi, Valentina, Borger, Darrell R., Duda, Dan G., Zhu, Andrew X.
Publié dans Cancer (2017)

Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer

par Meyerhardt, Jeffrey A., Ancukiewicz, Marek, Abrams, Thomas A., Schrag, Deborah, Enzinger, Peter C., Chan, Jennifer A., Kulke, Matthew H., Wolpin, Brian M., Goldstein, Michael, Blaszkowsky, Lawrence, Zhu, Andrew X., Elliott, Meaghan, Regan, Eileen, Jain, Rakesh K., Duda, Dan G.
Publié 2012

Phase 1/2 Study of Everolimus in Advanced Hepatocellular Carcinoma

par Zhu, Andrew X., Abrams, Thomas A., Miksad, Rebecca, Blaszkowsky, Lawrence S., Meyerhardt, Jeffrey A., Zheng, Hui, Muzikansky, Alona, Clark, Jeffrey W., Kwak, Eunice L., Schrag, Deborah, Jors, Kathryn R., Fuchs, Charles S., Iafrate, A. John, Borger, Darrell R., Ryan, David P.
Publié 2011

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients

par Rubinson, Douglas A., Hochster, Howard S., Ryan, David P., Wolpin, Brian M., McCleary, Nadine Jackson, Abrams, Thomas A., Chan, Jennifer A., Iqbal, Syma, Lenz, Heinz J., Lim, Dean, Rose, Jeffrey, Bekaii-Saab, Tanios, Chen, Helen X., Fuchs, Charles S., Ng, Kimmie
Publié 2013

Efficacy, safety, pharmacokinetics and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: A phase II study

par Zhu, Andrew X., Ancukiewicz, Marek, Supko, Jeffrey G., Sahani, Dushyant V., Blaszkowsky, Lawrence S., Meyerhardt, Jeffrey A., Abrams, Thomas A., McCleary, Nadine Jackson, Bhargava, Pankaj, Muzikansky, Alona, Sheehan, Susan, Regan, Eileen, Vasudev, Eamala, Knowles, Michelle, Fuchs, Charles S., Ryan, David P., Jain, Rakesh K., Duda, Dan G.
Publié 2013

Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial

par Brown, Justin C., Zhang, Sui, Ligibel, Jennifer, Irwin, Melinda L., Jones, Lee W., Campbell, Nancy, Pollak, Michael N., Sorrentino, Alexandra, Cartmel, Brenda, Harrigan, Maura, Tolaney, Sara M., Winer, Eric P., Ng, Kimmie, Abrams, Thomas A., Sanft, Tara, Douglas, Pamela, Hu, Frank B., Fuchs, Charles S., Meyerhardt, Jeffrey A.
Publié dans Cancer Prev Res (Phila) (2020)

A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC)

par Goyal, Lipika, Zheng, Hui, Abrams, Thomas A., Miksad, Rebecca, Bullock, Andrea J., Allen, Jill N., Yurgelun, Matthew B., Clark, Jeffrey W., Kambadakone, Avinash, Muzikansky, Alona, Knowles, Michelle, Galway, Aralee, Afflitto, Anthony J., Dinicola, Caroline F., Regan, Eileen, Hato, Tai, Mamessier, Emilie, Shigeta, Kohei, Jain, Rakesh K., Duda, Dan G., Zhu, Andrew X.
Publié dans Clin Cancer Res (2018)

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

par Zhu, Andrew X., Sahani, Dushyant V., Duda, Dan G., di Tomaso, Emmanuelle, Ancukiewicz, Marek, Catalano, Onofrio A., Sindhwani, Vivek, Blaszkowsky, Lawrence S., Yoon, Sam S., Lahdenranta, Johanna, Bhargava, Pankaj, Meyerhardt, Jeffrey, Clark, Jeffrey W., Kwak, Eunice L., Hezel, Aram F., Miksad, Rebecca, Abrams, Thomas A., Enzinger, Peter C., Fuchs, Charles S., Ryan, David P., Jain, Rakesh K.
Publié 2009

FOLFOX Plus Ziv-Aflibercept or Placebo in First-Line Metastatic Esophagogastric Adenocarcinoma: A Double-Blind, Randomized, Multicenter Phase 2 Trial

par Cleary, James M., Horick, Nora K., McCleary, Nadine Jackson, Abrams, Thomas A., Yurgelun, Matthew B., Azzoli, Christopher G., Rubinson, Douglas A., Brooks, Gabriel A., Chan, Jennifer A., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Goyal, Lipika, Meyerhardt, Jeffrey A., Ng, Kimmie, Schrag, Deborah, Savarese, Diane M.F., Graham, Christopher, Fitzpatrick, Bridget, Gibb, Kathryn A., Boucher, Yves, Duda, Dan G., Jain, Rakesh K., Fuchs, Charles S., Enzinger, Peter C.
Publié dans Cancer (2019)

Effect of High-Dose vs Standard-Dose Vitamin D(3) Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized...

par Ng, Kimmie, Nimeiri, Halla S., McCleary, Nadine J., Abrams, Thomas A., Yurgelun, Matthew B., Cleary, James M., Rubinson, Douglas A., Schrag, Deborah, Miksad, Rebecca, Bullock, Andrea J., Allen, Jill, Zuckerman, Dan, Chan, Emily, Chan, Jennifer A., Wolpin, Brian M., Constantine, Michael, Weckstein, Douglas J., Faggen, Meredith A., Thomas, Christian A., Kournioti, Chryssanthi, Yuan, Chen, Ganser, Christine, Wilkinson, Brittney, Mackintosh, Christopher, Zheng, Hui, Hollis, Bruce W., Meyerhardt, Jeffrey A., Fuchs, Charles S.
Publié dans JAMA (2019)

Effect of High-Dose vs Standard-Dose Vitamin D(3) Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial

par Brown, Justin C., Rosenthal, Michael H., Ma, Chao, Zhang, Sui, Nimeiri, Halla S., McCleary, Nadine J., Abrams, Thomas A., Yurgelun, Matthew B., Cleary, James M., Rubinson, Douglas A., Schrag, Deborah, Bullock, Andrea J., Allen, Jill, Zuckerman, Dan, Chan, Emily, Chan, Jennifer A., Wolpin, Brian, Constantine, Michael, Weckstein, Douglas J., Faggen, Meredith A., Thomas, Christian A., Kournioti, Chryssanthi, Yuan, Chen, Zheng, Hui, Hollis, Bruce W., Fuchs, Charles S., Ng, Kimmie, Meyerhardt, Jeffrey A.
Publié dans Cancers (Basel) (2020)

Hepatobiliary Cancers: Clinical Practice Guidelines in Oncology™

par Benson, Al B., Abrams, Thomas A., Ben-Josef, Edgar, Bloomston, P. Mark, Botha, Jean F., Clary, Bryan M., Covey, Anne, Curley, Steven A., D'Angelica, Michael I., Davila, Rene, Ensminger, William D., Gibbs, John F., Laheru, Daniel, Malafa, Mokenge P., Marrero, Jorge, Meranze, Steven G., Mulvihill, Sean J., Park, James O., Posey, James A., Sachdev, Jasgit, Salem, Riad, Sigurdson, Elin R., Sofocleous, Constantinos, Vauthey, Jean-Nicolas, Venook, Alan P., Goff, Laura Williams, Yen, Yun, Zhu, Andrew X.
Publié dans J Natl Compr Canc Netw (2009)

Hepatobiliary Cancers, Version 1.2017: Featured Updates to the NCCN Guidelines

par Benson, Al B., D’Angelica, Michael I., Abbott, Daniel E., Abrams, Thomas A., Alberts, Steven R., Saenz, Daniel Anaya, Are, Chandrakanth, Brown, Daniel B., Chang, Daniel T., Covey, Anne M., Hawkins, William, Iyer, Renuka, Jacob, Rojymon, Karachristos, Andrea, Kelley, R. Kate, Kim, Robin, Palta, Manisha, Park, James O., Sahai, Vaibhav, Schefter, Tracey, Schmidt, Carl, Sicklick, Jason K., Singh, Gagandeep, Sohal, Davendra, Stein, Stacey, Tian, G. Gary, Vauthey, Jean-Nicolas, Venook, Alan P., Zhu, Andrew X., Hoffmann, Karin G., Darlow, Susan
Publié dans J Natl Compr Canc Netw (2017)